Liu Jie, Zhu Xiangdong, Myo Saori, Lambertino Anissa T, Xu Chang, Boetticher Evan, Muñoz Nilda M, Sano Masaaki, Cordoba Martha, Learoyd Jonathan, Meliton Angelo, Johnson Malcolm, Leff Alan R
Section of Pulmonary and Critical Care Medicine, Department of Medicine, University of Chicago, Ill 60637, USA.
J Allergy Clin Immunol. 2005 Mar;115(3):493-500. doi: 10.1016/j.jaci.2004.11.010.
Glucocorticoids attenuate the population of eosinophils and T lymphocytes in asthmatic airways. The decrease in airway eosinophilia is caused both by accelerated cell death and by induction of blockade of integrin adhesion. In this study, we examined the hypothesis that annexin 1 surface expression, which is upregulated by the glucocorticoid receptor, prevents integrin adhesion essential to cell migration by blocking intracellular translocation of cytosolic group IV phospholipase A2 (cPLA2).
To examine the relationship of the glucocorticoid on annexin 1 expression and the effect of blockade of annexin 1 activity on adhesion of human eosinophils in vitro. To determine the relationship between annexin 1surface expression and nuclear membrane translocation of cPLA2.
Eosinophils isolated from human peripheral blood were pretreated with fluticasone propionate (FP), and beta2-integrin adhesion was measured after stimulation with IL-5 or eotaxin. Effects of FP on cPLA2 expression, phosphorylation, and translocation were determined. The role of annexin 1 was examined by using annexin 1 blocking antibody and/or mimetic peptides.
Fluticasone propionate decreased stimulated eosinophil adhesion and caused 4-fold increase in annexin 1 expression on the plasma membrane. Inhibition of adhesion by FP was blocked with annexin 1 blocking antibody. Annexin 1 N-terminal mimetic peptide also blocked beta2-integrin adhesion. Translocation of cPLA2 to the nuclear membrane was significantly blocked by incubation with FP. Blockade was reversed with annexin 1 blocking antibody.
Blockade of beta2-integrin adhesion by glucocorticoid is regulated by annexin 1, which blocks cPLA2 translocation to nuclear membrane.
糖皮质激素可减少哮喘气道中嗜酸性粒细胞和T淋巴细胞的数量。气道嗜酸性粒细胞减少是由细胞死亡加速和整合素黏附受阻诱导所致。在本研究中,我们检验了以下假设:糖皮质激素受体上调的膜联蛋白1表面表达通过阻断胞质IV型磷脂酶A2(cPLA2)的细胞内易位来阻止对细胞迁移至关重要的整合素黏附。
研究糖皮质激素对膜联蛋白1表达的影响以及阻断膜联蛋白1活性对体外人嗜酸性粒细胞黏附的作用。确定膜联蛋白1表面表达与cPLA2核膜易位之间的关系。
用人外周血分离的嗜酸性粒细胞用丙酸氟替卡松(FP)预处理,在用白细胞介素-5或嗜酸性粒细胞趋化因子刺激后测量β2整合素黏附。测定FP对cPLA2表达、磷酸化和易位的影响。通过使用膜联蛋白1阻断抗体和/或模拟肽来研究膜联蛋白1的作用。
丙酸氟替卡松降低了刺激的嗜酸性粒细胞黏附,并使质膜上的膜联蛋白1表达增加了4倍。FP对黏附的抑制作用被膜联蛋白1阻断抗体阻断。膜联蛋白1 N端模拟肽也阻断了β2整合素黏附。与FP孵育可显著阻断cPLA2向核膜的易位。膜联蛋白1阻断抗体可逆转这种阻断。
糖皮质激素对β2整合素黏附的阻断作用受膜联蛋白1调节,膜联蛋白1可阻断cPLA2向核膜的易位。